We partner with innovator and generic companies using our high-quality infrastructure and a global network of clinical trial sites, to launch novel therapies and new products for patients worldwide. Building on our strong foundation in global oncology studies, we offer solutions across multiple therapeutic domains, accelerating pipelines through AI and advanced real-world data capabilities. As an Integrated, Tech-driven & Global CRO we support the development of biotherapeutics and small molecules by blending scientific expertise with advanced technology. With offices in 9 countries and sites spanning across 26 geographies, we offer global reach and local expertise. Our integrated service model spans the entire drug development lifecycle, offering expertise in: 1. Preclinical studies 2. BA/BE Studies 3. Early Phase clinical trials 4. Late-phase clinical trials 5. Bioanalytical services 6. Biopharma solutions
$16M sweet spot round size
2004
$16M
from 2 investors over 1 rounds
Veeda Lifesciences raised $16M on July 24, 2021
Investors: Sabre Partners and + 4 Other investors